Add-On Therapy With Ertapenem In Infections With Multidrug Resistant Gram-Negative Bacteria: Pediatric Experience

Date
2017Author
Tanır Basaranoglu, Sevgen
Ozsurekci, Yasemin
Aykac, Kubra
Arıkan, Kamile Oktay
Buyukcam, Ayse
Cengiz, Ali Bulent
Ceyhan, Mehmet
Kara, Ates
xmlui.mirage2.itemSummaryView.MetaData
Show full item recordAbstract
Optimal therapy for infections with carbapenem resistant GNB is not well established due to the weakness of data. Patients presenting with bloodstream infections caused by multidrug resistant Klebsiella pneumoniae were treated with a combination treatment. Optimal therapy for infections with carbapenem resistant Gram-negative bacteria is a serious problem in pediatric patients. We presented three cases who were successfully treated with addition of ertapenem to the combination treatment for bacteremia with multidrug resistant Klebsiella pneumoniae. Dual carbapenem treatment approach is a new approach for these infections and requires more data in children.
URI
https://doi.org/10.1155/2017/8096420https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549487/
http://hdl.handle.net/11655/18954